GlassScriptPhysician profile
Ravinderan Krishnan
NPI 1952393373
$8,287.29
in general payments reported to CMS, 2019-2025
23 companies · $1,133 in 2025
The $1,133 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,869 · 2020: $279 · 2021: $408 · 2022: $1,713 · 2023: $1,063 · 2024: $1,822 · 2025: $1,133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,972 · Gift: $28.77 · Education: $18.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,971.66 |
| Gift | $28.77 |
| Education | $18.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,418.65 | 2019-2025 | Clareon, Centurion, Lensx |
| Rxsight INC | $2,037.67 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $1,699.06 | 2019-2024 | Tecnis Simplicity |
| Abbvie INC. | $713.43 | 2022-2025 | |
| Biotissue Holdings INC. | $446.84 | 2020-2022 | |
| Ivantis, INC | $163.96 | 2021 | |
| Allergan, INC. | $153.34 | 2019-2021 | |
| Optos, INC. | $99.23 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $82.05 | 2022 | |
| Ocular Therapeutix, INC. | $76.77 | 2022-2025 | Dextenza |
| Dompe US, INC. | $64.19 | 2020-2025 | Oxervate |
| Boston Scientific Corporation | $63.25 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Harrow Eye, LLC | $37.59 | 2025 | |
| Sight Sciences, INC. | $31.44 | 2020-2023 | Omni Surgical System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $29.50 | 2019 | |
| Genentech, INC. | $24.34 | 2023 | Vabysmo |
| Amgen INC. | $22.49 | 2025 | Tepezza |
| Bausch & Lomb Americas INC. | $18.61 | 2022 | |
| Lensar, INC. | $18.20 | 2023 | Lensar Laser System |
| Haag-Streit USA, INC. | $18.01 | 2023 | |
| Thea Pharma INC. | $16.85 | 2022 | |
| Oyster Point Pharma, INC. | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravinderan Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.